Cray (NASDAQ:CRAY) today announced that the Swiss National Supercomputing Centre (CSCS) in Manno, Switzerland has awarded a contract to Cray to acquire a next-generation Cray XMT supercomputer. The announcement, which is being made in conjunction with a CSCS-hosted workshop focused on large-scale data analysis, marks Cray's first order for the Company's next-generation Cray XMT system.

Cray Inc., incorporated in December 1987, designs, develops, manufactures, markets and services high-performance computing (HPC) systems, known as supercomputers and provides engineering services related to HPC systems and solutions. The Company sells its HPC systems and services primarily, through a direct sales force that operates throughout the United States and in Canada, Europe, Japan and Asia-Pacific. The Company's flagship supercomputers, the Cray XT products enable users to address scientific and engineering computing problems.

LifePoint Hospitals, Inc. (NASDAQ:LPNT) said it expects 2011 earnings of $2.80 to $3.10 per share on revenue of $3.50 billion to $3.60 billion. The current consensus earnings estimate is $3.08 per share on revenue of $3.50 billion for the year ending December 31, 2011.

LifePoint Hospitals, Inc. (LifePoint), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States. As of December 31, 2009, the Company owned or leased 47 hospitals through subsidiaries, having a total of 5,552 licensed beds, and serving communities in 17 states.

Hospitality Props (NYSE:HPT) beats by $0.04, reports revs in-line (HPT) 25.50 : Reports Q4 (Dec) funds from operations of $0.85 per share, $0.04 better than the Thomson Reuters consensus of $0.81; revenues rose 6.6% year/year to $267.8 mln vs the $265.2 mln consensus.

Hospitality Properties Trust (HPT) is a real estate investment trust (REIT). As of December 31, 2009, the Company owned 289 hotels with 42,880 rooms or suites, and 185 travel centers. Its properties are located in 44 states in the United States, Canada and Puerto Rico.

Eldorado Gold (NYSE:EGO) misses by $0.02, beats on revs. Reports Q4 (Dec) earnings of $0.08 per share, $0.02 worse than the Thomson Reuters consensus of $0.10; revenues rose 47.3% year/year to $212.9 mln vs the $203.3 mln consensus. Produced 148,374 ounces of gold, an increase of 15% over Q4, 2009 at an average cash operating cost of $418 per ounce (Total cash cost $460 per ounce). Sold 149,022 ounces of gold at an average realized price of $1,373 per ounce; which generated revenue 42% higher than Q4, 2009

Eldorado Gold Corporation (Eldorado) is engaged in gold mining and related activities including exploration, development, extraction, processing and reclamation. The Company owns and operates the Kisladag gold mine (Kisladag) in Turkey, the Tanjianshan (TJS) (90% interest), Jinfeng (82% interest) and White Mountain (95% interest) gold mines in China, and it is developing gold projects in China (Eastern Dragon), Turkey (Efemcukuru) and Greece (Perama Hill).

Chelsea Therapeutics (NASDAQ:CHTP) prices a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammatory bowel disease and cancer.

BullsEyeMicrocaps.com is not a registered investment advisers or broker/dealer. BullsEyeMicrocaps.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: BullsEyeMicrocaps.com has not been compensated for any stocks listed in this stock news report.